We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model.
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (βJourney Medicalβ or βthe Companyβ) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...
New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter ended March 31, 2024 were $13.0 million, a...
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (βJourney Medicalβ or the βCompanyβ) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the...
SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (βJourney Medicalβ or βthe Companyβ) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (βJourney Medicalβ or βthe Companyβ) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...
Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 Achieved $15.6 million in operating cost savings...
SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (βJourney Medicalβ or βthe Companyβ), a commercial-stage pharmaceutical company that primarily...
SCOTTSDALE, Ariz., March 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (βJourney Medicalβ or the βCompanyβ) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.89 | 19.0170940171 | 4.68 | 6.15 | 4.52 | 208462 | 5.5458395 | CS |
4 | 1.98 | 55.1532033426 | 3.59 | 6.15 | 3.2001 | 119406 | 4.64163026 | CS |
12 | 2.07 | 59.1428571429 | 3.5 | 6.15 | 2.85 | 141418 | 3.99165657 | CS |
26 | -1.23 | -18.0882352941 | 6.8 | 8.11 | 2.85 | 189869 | 4.96832491 | CS |
52 | 3.53 | 173.039215686 | 2.04 | 8.11 | 1.52 | 173501 | 4.29804791 | CS |
156 | -3.13 | -35.9770114943 | 8.7 | 10.2 | 1.02 | 97837 | 4.33033535 | CS |
260 | -4.33 | -43.7373737374 | 9.9 | 25.99 | 1.02 | 377505 | 11.25918689 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions